Skip to content
GenoLensGenoLens

TRPS1

Chr 8q23.3

transcriptional repressor GATA binding 1

Aliases:
LGCR, GC79
MANE:
ENST00000395715.8

Annotations refreshed 9 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • DDG2P

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
  • Fetal anomalies

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
  • Limb disorders

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
  • Skeletal dysplasia

    MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
  • Intellectual disability

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
  • Osteogenesis imperfecta

Disease associations (Open Targets)

  • Trichorhinophalangeal syndrome type 1 and 3

    0.81
  • trichorhinophalangeal syndrome type I

    0.64
  • hereditary disease

    0.54
  • Langer-Giedion syndrome

    0.52
  • Hypercholesterolemia

    0.50
  • Abnormality of the skeletal system

    0.49
  • type 2 diabetes mellitus

    0.48
  • trichorhinophalangeal syndrome type I or III

    0.48
  • diverticular disease

    0.46
  • metabolic disease

    0.46

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Zinc finger transcription factor Trps1

Transcriptional repressor. Binds specifically to GATA sequences and represses expression of GATA-regulated genes at selected sites and stages in vertebrate development. Regulates chondrocyte proliferation and differentiation. Executes multiple functions in proliferating chondrocytes, expanding the region of distal chondrocytes, activating proliferation in columnar cells and supporting the differentiation of columnar into hypertrophic chondrocytes

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.